Author:
Shukla Hitesh,Mason Jessica Louise,Sabyah Abdullah
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine
Reference98 articles.
1. World Health Organization (WHO). (2017). Cardiovascular diseases (CVDs): Fact Sheet. http://www.who.int/mediacentre/factsheets/fs317/en/ . Accessed 10 Aug 2017.
2. Prescriptions Dispensed in the Community: England 2005-2015. (2016). 1st ed. [ebook] Health and Social Care Information Centre. http://content.digital.nhs.uk/catalogue/PUB20664/pres-disp-com-eng-2005-1 . Accessed 17 Aug 2017.
3. Altman R. Pharmacogenomics: “noninferiority” is sufficient for initial implementation. Clin Pharmacol Ther. 2011;89(3):348–50.
4. Epstein RS, Moyer TP, Aubert RE, O’Kane DJ, Xia F, Verbrugge RR, Gage BF, Teagarden JR. Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study). J Am Coll Cardiol. 2010;55(25):2804–12.
5. Caudle K, Klein T, Hoffman J, Muller D, Whirl-Carrillo M, Gong L, McDonagh E, Sangkuhl K, Thorn C, Schwab M, Agundez J, Freimuth R, Huser V, Michael Lee M, Iwuchukwu O, Crews K, Scott S, Wadelius M, Swen J, Tyndale R, Stein C, Roden D, Relling M, Williams M, Johnson S. Incorporation of pharmacogenomics into routine clinical practice: the clinical pharmacogenetics implementation consortium (CPIC) guideline development process. Curr Drug Metab. 2014;15(2):209–17.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献